RU2016107378A3 - - Google Patents

Download PDF

Info

Publication number
RU2016107378A3
RU2016107378A3 RU2016107378A RU2016107378A RU2016107378A3 RU 2016107378 A3 RU2016107378 A3 RU 2016107378A3 RU 2016107378 A RU2016107378 A RU 2016107378A RU 2016107378 A RU2016107378 A RU 2016107378A RU 2016107378 A3 RU2016107378 A3 RU 2016107378A3
Authority
RU
Russia
Application number
RU2016107378A
Other languages
Russian (ru)
Other versions
RU2734760C2 (ru
RU2016107378A (ru
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2016107378A publication Critical patent/RU2016107378A/ru
Publication of RU2016107378A3 publication Critical patent/RU2016107378A3/ru
Application granted granted Critical
Publication of RU2734760C2 publication Critical patent/RU2734760C2/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RU2016107378A 2013-08-02 2014-08-01 Противоинфекционные соединения RU2734760C2 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361861750P 2013-08-02 2013-08-02
US61/861,750 2013-08-02
PCT/EP2014/066614 WO2015014993A2 (en) 2013-08-02 2014-08-01 Anti-infective compounds

Publications (3)

Publication Number Publication Date
RU2016107378A RU2016107378A (ru) 2017-09-07
RU2016107378A3 true RU2016107378A3 (https=) 2018-03-29
RU2734760C2 RU2734760C2 (ru) 2020-10-23

Family

ID=51260879

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2016107378A RU2734760C2 (ru) 2013-08-02 2014-08-01 Противоинфекционные соединения

Country Status (12)

Country Link
US (1) US20160185774A1 (https=)
EP (1) EP3027615B1 (https=)
JP (3) JP2016525562A (https=)
KR (1) KR102292293B1 (https=)
CN (2) CN109575018A (https=)
DK (1) DK3027615T3 (https=)
ES (1) ES2883565T3 (https=)
HU (1) HUE056198T2 (https=)
PH (1) PH12016500207A1 (https=)
RU (1) RU2734760C2 (https=)
SG (1) SG11201600686QA (https=)
WO (1) WO2015014993A2 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA125171C2 (uk) 2015-07-02 2022-01-26 Янссен Саєнсиз Айрленд Юсі Антибактеріальні сполуки
KR20180053386A (ko) * 2015-09-17 2018-05-21 마빈 제이. 밀러 마이코박테리아 감염에 대해 유용한 벤질 아민-함유 헤테로사이클릭 화합물 및 조성물
JP2019518046A (ja) * 2016-06-16 2019-06-27 ヤンセン・サイエンシズ・アイルランド・アンリミテッド・カンパニー 抗菌薬としての複素環式化合物
US20200308169A1 (en) 2016-06-16 2020-10-01 Janssen Sciences Ireland Unlimited Company Heterocyclic compounds as antibacterials
KR20190121315A (ko) 2017-03-01 2019-10-25 얀센 사이언시즈 아일랜드 언리미티드 컴퍼니 병용 요법
CN111246848A (zh) * 2017-10-05 2020-06-05 快尔生物技术公司 与抗结核药物组合的环稠和的噻唑并2-吡啶酮
CN108101828B (zh) * 2018-01-15 2021-05-04 西华师范大学 3-吲哚基甲酰胺类化合物及其制备方法
CN108159049B (zh) * 2018-02-01 2021-01-05 中国科学院广州生物医药与健康研究院 一种吡啶类化合物的新用途
WO2020113094A1 (en) 2018-11-30 2020-06-04 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
JPWO2020203609A1 (https=) * 2019-03-29 2020-10-08
JP2022081710A (ja) * 2019-03-29 2022-06-01 ユーティアイ リミテッド パートナーシップ 関節リウマチを治療するためのt型カルシウムチャネル阻害剤の使用
TWI861208B (zh) * 2019-09-10 2024-11-11 日商鹽野義製藥股份有限公司 對分枝桿菌感染有用之含苄胺的 5,6-雜芳族化合物
US20220340564A1 (en) 2019-09-13 2022-10-27 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
CN114450288A (zh) * 2019-09-30 2022-05-06 爱尔兰詹森科学公司 4-喹啉酮抗细菌化合物
MX2022003816A (es) * 2019-09-30 2022-05-06 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.
KR102381397B1 (ko) * 2020-07-10 2022-03-30 경희대학교 산학협력단 신규 나프토퀴논 유도체 화합물 및 이를 포함하는 항균용 조성물
MX2023010947A (es) 2021-03-16 2023-11-29 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.
MX2023010941A (es) 2021-03-17 2023-11-28 Janssen Sciences Ireland Unlimited Co Compuestos antibacterianos.
CA3211592A1 (en) 2021-03-17 2022-09-22 Jerome Emile Georges Guillemont Antibacterial compounds
EP4423097A1 (en) 2021-10-28 2024-09-04 Janssen Sciences Ireland Unlimited Company Imidazopyridine amides and related compounds for use in the treatment of bacterial infections
JP2025530847A (ja) * 2022-09-16 2025-09-17 北京華益健康薬物研究中心 Mettl3阻害剤化合物、その医薬組成物及び用途
WO2024089170A1 (en) 2022-10-27 2024-05-02 Janssen Sciences Ireland Unlimited Company Antibacterial compounds
WO2024223859A1 (en) 2023-04-26 2024-10-31 Janssen Pharmaceutica Nv Antibacterial compounds
KR20260041840A (ko) 2023-07-18 2026-03-27 얀센 파마슈티카 엔브이 베다퀼린, 프레토마니드 또는 델라마니드, 및 시토크롬 bc1 억제제를 포함하는 적어도 세 가지 항생제의 조합 제품 및 미코박테리아 감염 치료에서의 이들의 용도
CN117946118A (zh) * 2024-01-15 2024-04-30 珃诺生物医药科技(杭州)有限公司 一种靶向降解erk5蛋白的化合物及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2906250B1 (fr) * 2006-09-22 2008-10-31 Sanofi Aventis Sa Derives de 2-aryl-6phenyl-imidazo(1,2-a) pyridines, leur preparation et leur application en therapeutique
US20100298314A1 (en) * 2006-12-20 2010-11-25 Schering Corporation Novel jnk inhibitors
WO2009140101A2 (en) * 2008-05-12 2009-11-19 Boehringer Ingelheim International Gmbh Imidazopyridine compounds useful as mmp-13 inhibitors
EP2496578A4 (en) * 2009-11-05 2013-08-21 Univ Notre Dame Du Lac IMIDAZO [1,2-A] PYRIDINE COMPOUNDS, THEIR SYNTHESIS AND METHODS OF USE THEREOF
SG184073A1 (en) * 2010-03-18 2012-10-30 Pasteur Institut Korea Anti-infective compounds
KR20140093610A (ko) * 2011-04-21 2014-07-28 재단법인 한국파스퇴르연구소 소염 화합물
CN103324035B (zh) * 2013-06-20 2015-07-01 深圳市华星光电技术有限公司 掩膜板和阵列基板的制作方法

Also Published As

Publication number Publication date
PH12016500207A1 (en) 2016-04-25
ES2883565T3 (es) 2021-12-09
EP3027615B1 (en) 2021-07-21
SG11201600686QA (en) 2016-02-26
RU2734760C2 (ru) 2020-10-23
KR20170082450A (ko) 2017-07-14
DK3027615T3 (da) 2021-10-25
JP6757768B2 (ja) 2020-09-23
WO2015014993A3 (en) 2015-04-02
JP2018158941A (ja) 2018-10-11
CN105745208A (zh) 2016-07-06
KR102292293B1 (ko) 2021-08-23
WO2015014993A2 (en) 2015-02-05
HUE056198T2 (hu) 2022-02-28
US20160185774A1 (en) 2016-06-30
CN109575018A (zh) 2019-04-05
RU2016107378A (ru) 2017-09-07
JP2019131606A (ja) 2019-08-08
EP3027615A2 (en) 2016-06-08
JP2016525562A (ja) 2016-08-25

Similar Documents

Publication Publication Date Title
BR112015007533A2 (https=)
BR112014017733A2 (https=)
BR112016001143A2 (https=)
BR112014017739A2 (https=)
BR112014019326A2 (https=)
BR112016003819A2 (https=)
BR112014018480A2 (https=)
BR112014017855A2 (https=)
BR112014017765A2 (https=)
BR112014017669A2 (https=)
RU2016107378A3 (https=)
BR112014021878A2 (https=)
BR112016005365A2 (https=)
BR112016015033A2 (https=)
BR112014018468A2 (https=)
BR112014017901A2 (https=)
BR112014018207A2 (https=)
BR112015019515A2 (https=)
BR112015015948A2 (https=)
BR112016013278A2 (https=)
BR112016003520A2 (https=)
BR112014017722A2 (https=)
BR112016000485A2 (https=)
BR112014017794A2 (https=)
BR112014017653A2 (https=)